SMAD4 and neoplasm: As for Smad4 immunohistochemical analysis in AVC, the tumor sample AVC4 bearing a R361H mutation with 24% frequency displayed a mixture of negative and positive regions, the latter accounting for about 15–20% of cancer cells, while non-mutated samples had a homogeneously positive immunohistochemical pattern (Figure 4).